China RMB: HS30: Pharmaceutical Products
Export: HS 8: Angong Niuhuang Wan, in Measured Doses or in Retail Packings
CN: Export: HS 8: Angong Niuhuang Wan, in Measured Doses or in Retail Packings data was reported at 13.773 RMB mn in Mar 2025. This records an increase from the previous number of 1.797 RMB mn for Feb 2025. CN: Export: HS 8: Angong Niuhuang Wan, in Measured Doses or in Retail Packings data is updated monthly, averaging 3.459 RMB mn from Jan 2015 (Median) to Mar 2025, with 117 observations. The data reached an all-time high of 73.495 RMB mn in Aug 2020 and a record low of 0.005 RMB mn in Jun 2017. CN: Export: HS 8: Angong Niuhuang Wan, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 16.577 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Angong Niuhuang Wan, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Bacteria and Virus
CN: Export: HS 8: Bacteria and Virus data was reported at 45.741 RMB mn in Mar 2025. This records an increase from the previous number of 41.684 RMB mn for Feb 2025. CN: Export: HS 8: Bacteria and Virus data is updated monthly, averaging 17.545 RMB mn from Jan 2022 (Median) to Mar 2025, with 39 observations. The data reached an all-time high of 50.452 RMB mn in Dec 2024 and a record low of 8.996 RMB mn in Apr 2022. CN: Export: HS 8: Bacteria and Virus data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 44.298 Nov 2024 | monthly | Jan 2022 - Nov 2024 |
View China's Export: HS 8: Bacteria and Virus from Jan 2022 to Nov 2024 in the chart:
Export: HS 8: Blood-Grouping Reagents
CN: Export: HS 8: Blood-Grouping Reagents data was reported at 0.655 RMB mn in Dec 2021. This records an increase from the previous number of 0.396 RMB mn for Nov 2021. CN: Export: HS 8: Blood-Grouping Reagents data is updated monthly, averaging 0.599 RMB mn from Jan 2015 (Median) to Dec 2021, with 84 observations. The data reached an all-time high of 2.939 RMB mn in Jun 2018 and a record low of 0.039 RMB mn in Feb 2020. CN: Export: HS 8: Blood-Grouping Reagents data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.655 Dec 2021 | monthly | Jan 2015 - Dec 2021 |
View China's Export: HS 8: Blood-Grouping Reagents from Jan 2015 to Dec 2021 in the chart:
Export: HS 8: Cell Therapy Products
CN: Export: HS 8: Cell Therapy Products data was reported at 1.405 RMB mn in Mar 2025. This records an increase from the previous number of 0.128 RMB mn for Jan 2025. CN: Export: HS 8: Cell Therapy Products data is updated monthly, averaging 0.004 RMB mn from Aug 2022 (Median) to Mar 2025, with 9 observations. The data reached an all-time high of 1.646 RMB mn in Dec 2024 and a record low of 0.001 RMB mn in Apr 2023. CN: Export: HS 8: Cell Therapy Products data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.004 Sep 2024 | monthly | Aug 2022 - Sep 2024 |
View China's Export: HS 8: Cell Therapy Products from Aug 2022 to Sep 2024 in the chart:
Export: HS 8: Contraceptive Preparations Based on Hormones
CN: Export: HS 8: Contraceptive Preparations Based on Hormones data was reported at 18.423 RMB mn in Mar 2025. This records an increase from the previous number of 6.352 RMB mn for Feb 2025. CN: Export: HS 8: Contraceptive Preparations Based on Hormones data is updated monthly, averaging 14.549 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 31.202 RMB mn in Dec 2019 and a record low of 3.433 RMB mn in Sep 2021. CN: Export: HS 8: Contraceptive Preparations Based on Hormones data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 16.155 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Contraceptive Preparations Based on Hormones from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Genetics Material and Gene-Modified Organism
CN: Export: HS 8: Genetics Material and Gene-Modified Organism data was reported at 0.028 RMB mn in Nov 2024. This records an increase from the previous number of 0.000 RMB mn for Apr 2024. CN: Export: HS 8: Genetics Material and Gene-Modified Organism data is updated monthly, averaging 0.391 RMB mn from Jan 2015 (Median) to Nov 2024, with 101 observations. The data reached an all-time high of 29.512 RMB mn in Nov 2018 and a record low of 0.000 RMB mn in May 2023. CN: Export: HS 8: Genetics Material and Gene-Modified Organism data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.028 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Genetics Material and Gene-Modified Organism from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Malaria Diagnostic Test Kits
CN: Export: HS 8: Malaria Diagnostic Test Kits data was reported at 24.499 RMB mn in Dec 2021. This records an increase from the previous number of 2.183 RMB mn for Nov 2021. CN: Export: HS 8: Malaria Diagnostic Test Kits data is updated monthly, averaging 0.319 RMB mn from Jan 2017 (Median) to Dec 2021, with 60 observations. The data reached an all-time high of 24.499 RMB mn in Dec 2021 and a record low of 0.020 RMB mn in Feb 2020. CN: Export: HS 8: Malaria Diagnostic Test Kits data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 24.499 Dec 2021 | monthly | Jan 2017 - Dec 2021 |
View China's Export: HS 8: Malaria Diagnostic Test Kits from Jan 2017 to Dec 2021 in the chart:
Export: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes
CN: Export: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data was reported at 1.171 RMB mn in Dec 2016. This records a decrease from the previous number of 7.199 RMB mn for Nov 2016. CN: Export: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data is updated monthly, averaging 1.056 RMB mn from Jan 2015 (Median) to Dec 2016, with 24 observations. The data reached an all-time high of 7.199 RMB mn in Nov 2016 and a record low of 0.051 RMB mn in Mar 2015. CN: Export: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 1.171 Dec 2016 | monthly | Jan 2015 - Dec 2016 |
View China's Export: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes from Jan 2015 to Dec 2016 in the chart:
Export: HS 8: Medicaments of Ampicillin, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Ampicillin, Neither in Measured Doses Nor in Retail Packings data was reported at 17.220 RMB mn in Mar 2025. This records an increase from the previous number of 1.776 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Ampicillin, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 3.709 RMB mn from Jan 2015 (Median) to Mar 2025, with 122 observations. The data reached an all-time high of 17.220 RMB mn in Mar 2025 and a record low of 0.100 RMB mn in Jul 2018. CN: Export: HS 8: Medicaments of Ampicillin, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 6.611 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Ampicillin, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data was reported at 276.133 RMB mn in Mar 2025. This records an increase from the previous number of 212.095 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 183.074 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 320.887 RMB mn in Jan 2024 and a record low of 85.322 RMB mn in Feb 2017. CN: Export: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 263.354 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data was reported at 324.291 RMB mn in Mar 2025. This records an increase from the previous number of 202.520 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 145.060 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 350.529 RMB mn in Dec 2024 and a record low of 57.248 RMB mn in Sep 2016. CN: Export: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 350.529 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Export: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings from Jan 2015 to Dec 2024 in the chart:
Export: HS 8: Medicaments of Artemisinins or Their Derivatives, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Artemisinins or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data was reported at 0.111 RMB mn in Mar 2025. This records an increase from the previous number of 0.038 RMB mn for Jan 2025. CN: Export: HS 8: Medicaments of Artemisinins or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.193 RMB mn from Nov 2018 (Median) to Mar 2025, with 47 observations. The data reached an all-time high of 2.124 RMB mn in Oct 2024 and a record low of 0.002 RMB mn in Feb 2024. CN: Export: HS 8: Medicaments of Artemisinins or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.085 Nov 2024 | monthly | Nov 2018 - Nov 2024 |
View China's Export: HS 8: Medicaments of Artemisinins or Their Derivatives, Neither in Measured Doses Nor in Retail Packings from Nov 2018 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Biphenyl Dicarbxybte, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Biphenyl Dicarbxybte, in Measured Doses or in Retail Packings data was reported at 1.906 RMB mn in Mar 2025. This records an increase from the previous number of 1.664 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Biphenyl Dicarbxybte, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.858 RMB mn from Feb 2015 (Median) to Mar 2025, with 75 observations. The data reached an all-time high of 9.848 RMB mn in Oct 2019 and a record low of 0.000 RMB mn in Jul 2023. CN: Export: HS 8: Medicaments of Biphenyl Dicarbxybte, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.448 Nov 2024 | monthly | Feb 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Biphenyl Dicarbxybte, in Measured Doses or in Retail Packings from Feb 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data was reported at 0.004 RMB mn in Mar 2025. This records a decrease from the previous number of 1.604 RMB mn for May 2024. CN: Export: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.765 RMB mn from Mar 2015 (Median) to Mar 2025, with 44 observations. The data reached an all-time high of 13.005 RMB mn in May 2016 and a record low of 0.000 RMB mn in Sep 2021. CN: Export: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 1.604 May 2024 | monthly | Mar 2015 - May 2024 |
View China's Export: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings from Mar 2015 to May 2024 in the chart:
Export: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data was reported at 8.472 RMB mn in Mar 2025. This records an increase from the previous number of 6.802 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 5.973 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 37.268 RMB mn in Feb 2017 and a record low of 1.265 RMB mn in Jun 2016. CN: Export: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 7.965 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data was reported at 0.141 RMB mn in Mar 2025. This records a decrease from the previous number of 15.120 RMB mn for Jan 2025. CN: Export: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.580 RMB mn from Jan 2015 (Median) to Mar 2025, with 110 observations. The data reached an all-time high of 52.036 RMB mn in Jul 2021 and a record low of 0.005 RMB mn in Jul 2022. CN: Export: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 1.071 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Cefotaxime, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Cefotaxime, in Measured Doses or in Retail Packings data was reported at 2.626 RMB mn in Mar 2025. This records an increase from the previous number of 1.788 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Cefotaxime, in Measured Doses or in Retail Packings data is updated monthly, averaging 3.724 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 11.377 RMB mn in Jul 2022 and a record low of 1.092 RMB mn in Sep 2015. CN: Export: HS 8: Medicaments of Cefotaxime, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 4.013 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Cefotaxime, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data was reported at 7.317 RMB mn in Mar 2025. This records an increase from the previous number of 5.405 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data is updated monthly, averaging 4.446 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 99.314 RMB mn in Jun 2024 and a record low of 0.458 RMB mn in Aug 2019. CN: Export: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 6.259 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Ceftezole, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Ceftezole, Neither in Measured Doses Nor in Retail Packings data was reported at 0.042 RMB mn in Mar 2021. CN: Export: HS 8: Medicaments of Ceftezole, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.042 RMB mn from Mar 2021 (Median) to Mar 2021, with 1 observations. The data reached an all-time high of 0.042 RMB mn in Mar 2021 and a record low of 0.042 RMB mn in Mar 2021. CN: Export: HS 8: Medicaments of Ceftezole, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.042 Mar 2021 | monthly | Mar 2021 - Mar 2021 |
View China's Export: HS 8: Medicaments of Ceftezole, Neither in Measured Doses Nor in Retail Packings from Mar 2021 to Mar 2021 in the chart:
Export: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data was reported at 0.280 RMB mn in Oct 2020. This records an increase from the previous number of 0.272 RMB mn for Jul 2020. CN: Export: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.105 RMB mn from Feb 2015 (Median) to Oct 2020, with 16 observations. The data reached an all-time high of 0.280 RMB mn in Oct 2020 and a record low of 0.050 RMB mn in Jun 2015. CN: Export: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.280 Oct 2020 | monthly | Feb 2015 - Oct 2020 |
View China's Export: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings from Feb 2015 to Oct 2020 in the chart:
Export: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data was reported at 74.967 RMB mn in Mar 2025. This records an increase from the previous number of 51.555 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data is updated monthly, averaging 40.103 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 101.815 RMB mn in Jan 2025 and a record low of 10.911 RMB mn in Feb 2020. CN: Export: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 85.062 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data was reported at 0.044 RMB mn in Mar 2025. This records a decrease from the previous number of 0.138 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.271 RMB mn from Jan 2015 (Median) to Mar 2025, with 108 observations. The data reached an all-time high of 7.579 RMB mn in Dec 2019 and a record low of 0.000 RMB mn in Jun 2018. CN: Export: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.108 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data was reported at 0.000 RMB mn in Feb 2025. This records a decrease from the previous number of 0.003 RMB mn for Dec 2024. CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.082 RMB mn from Mar 2015 (Median) to Feb 2025, with 55 observations. The data reached an all-time high of 0.653 RMB mn in Mar 2018 and a record low of 0.000 RMB mn in Jan 2023. CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.001 Oct 2024 | monthly | Mar 2015 - Oct 2024 |
View China's Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings from Mar 2015 to Oct 2024 in the chart:
Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, in Measured Doses or in Retail Packings data was reported at 778.703 RMB mn in Mar 2025. This records an increase from the previous number of 355.943 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 28.966 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 1,274.013 RMB mn in Mar 2024 and a record low of 1.953 RMB mn in Feb 2020. CN: Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 742.185 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data was reported at 3.923 RMB mn in Feb 2025. This records an increase from the previous number of 0.006 RMB mn for Aug 2024. CN: Export: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.002 RMB mn from Feb 2015 (Median) to Feb 2025, with 20 observations. The data reached an all-time high of 3.923 RMB mn in Feb 2025 and a record low of 0.000 RMB mn in Dec 2023. CN: Export: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.006 Aug 2024 | monthly | Feb 2015 - Aug 2024 |
View China's Export: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings from Feb 2015 to Aug 2024 in the chart:
Export: HS 8: Medicaments of Mixed or Unmixed Products, nes, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Mixed or Unmixed Products, nes, in Measured Doses or in Retail Packings data was reported at 1,839.187 RMB mn in Mar 2025. This records an increase from the previous number of 1,409.175 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Mixed or Unmixed Products, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 1,299.256 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 2,460.311 RMB mn in Jun 2018 and a record low of 486.643 RMB mn in Feb 2020. CN: Export: HS 8: Medicaments of Mixed or Unmixed Products, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2,151.572 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Export: HS 8: Medicaments of Mixed or Unmixed Products, nes, in Measured Doses or in Retail Packings from Jan 2015 to Dec 2024 in the chart:
Export: HS 8: Medicaments of Other Alkaloids or Their Derivatives, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Other Alkaloids or Their Derivatives, in Measured Doses or in Retail Packings data was reported at 7.273 RMB mn in Mar 2025. This records an increase from the previous number of 3.793 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Other Alkaloids or Their Derivatives, in Measured Doses or in Retail Packings data is updated monthly, averaging 7.704 RMB mn from Jan 2017 (Median) to Mar 2025, with 99 observations. The data reached an all-time high of 65.061 RMB mn in Dec 2020 and a record low of 0.448 RMB mn in Feb 2020. CN: Export: HS 8: Medicaments of Other Alkaloids or Their Derivatives, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 15.545 Nov 2024 | monthly | Jan 2017 - Nov 2024 |
View China's Export: HS 8: Medicaments of Other Alkaloids or Their Derivatives, in Measured Doses or in Retail Packings from Jan 2017 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Other Antimalarial Active Principles, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Other Antimalarial Active Principles, in Measured Doses or in Retail Packings data was reported at 27.014 RMB mn in Mar 2025. This records a decrease from the previous number of 101.356 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Other Antimalarial Active Principles, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.888 RMB mn from Feb 2017 (Median) to Mar 2025, with 80 observations. The data reached an all-time high of 109.628 RMB mn in Jan 2024 and a record low of 0.013 RMB mn in Jul 2021. CN: Export: HS 8: Medicaments of Other Antimalarial Active Principles, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 3.536 Nov 2024 | monthly | Feb 2017 - Nov 2024 |
View China's Export: HS 8: Medicaments of Other Antimalarial Active Principles, in Measured Doses or in Retail Packings from Feb 2017 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Other Cephamycins, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Other Cephamycins, Neither in Measured Doses Nor in Retail Packings data was reported at 29.534 RMB mn in Mar 2025. This records an increase from the previous number of 11.915 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Other Cephamycins, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 12.895 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 31.299 RMB mn in May 2020 and a record low of 1.718 RMB mn in Feb 2016. CN: Export: HS 8: Medicaments of Other Cephamycins, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 15.906 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Other Cephamycins, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data was reported at 15.115 RMB mn in Mar 2025. This records an increase from the previous number of 6.824 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data is updated monthly, averaging 118.896 RMB mn from Jan 2015 (Median) to Mar 2025, with 104 observations. The data reached an all-time high of 1,167.817 RMB mn in Jan 2022 and a record low of 0.001 RMB mn in Nov 2022. CN: Export: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 10.140 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data was reported at 4.644 RMB mn in Mar 2025. This records an increase from the previous number of 1.847 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 3.272 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 13.592 RMB mn in Oct 2021 and a record low of 0.022 RMB mn in Aug 2015. CN: Export: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2.179 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Penicillin V, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Penicillin V, Neither in Measured Doses Nor in Retail Packings data was reported at 0.054 RMB mn in Jan 2017. CN: Export: HS 8: Medicaments of Penicillin V, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.054 RMB mn from Jan 2017 (Median) to Jan 2017, with 1 observations. The data reached an all-time high of 0.054 RMB mn in Jan 2017 and a record low of 0.054 RMB mn in Jan 2017. CN: Export: HS 8: Medicaments of Penicillin V, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.054 Jan 2017 | monthly | Jan 2017 - Jan 2017 |
View China's Export: HS 8: Medicaments of Penicillin V, Neither in Measured Doses Nor in Retail Packings from Jan 2017 to Jan 2017 in the chart:
Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, Neither in Measured Doses Nor in Retail Packings data was reported at 0.285 RMB mn in Nov 2024. This records an increase from the previous number of 0.039 RMB mn for Jun 2020. CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.162 RMB mn from Jun 2020 (Median) to Nov 2024, with 2 observations. The data reached an all-time high of 0.285 RMB mn in Nov 2024 and a record low of 0.039 RMB mn in Jun 2020. CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.285 Nov 2024 | monthly | Jun 2020 - Nov 2024 |
View China's Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, Neither in Measured Doses Nor in Retail Packings from Jun 2020 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data was reported at 0.525 RMB mn in Mar 2025. This records an increase from the previous number of 0.104 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.100 RMB mn from May 2017 (Median) to Mar 2025, with 48 observations. The data reached an all-time high of 0.716 RMB mn in Nov 2021 and a record low of 0.000 RMB mn in Aug 2017. CN: Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.141 Nov 2024 | monthly | May 2017 - Nov 2024 |
View China's Export: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings from May 2017 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale
CN: Export: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data was reported at 0.205 RMB mn in Dec 2016. This records an increase from the previous number of 0.042 RMB mn for Apr 2015. CN: Export: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data is updated monthly, averaging 0.123 RMB mn from Apr 2015 (Median) to Dec 2016, with 2 observations. The data reached an all-time high of 0.205 RMB mn in Dec 2016 and a record low of 0.042 RMB mn in Apr 2015. CN: Export: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.205 Dec 2016 | monthly | Apr 2015 - Dec 2016 |
View China's Export: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale from Apr 2015 to Dec 2016 in the chart:
Export: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale
CN: Export: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data was reported at 2.928 RMB mn in Dec 2016. This records a decrease from the previous number of 4.582 RMB mn for Nov 2016. CN: Export: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data is updated monthly, averaging 3.221 RMB mn from Jan 2015 (Median) to Dec 2016, with 24 observations. The data reached an all-time high of 6.451 RMB mn in Oct 2016 and a record low of 1.266 RMB mn in May 2015. CN: Export: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2.928 Dec 2016 | monthly | Jan 2015 - Dec 2016 |
View China's Export: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale from Jan 2015 to Dec 2016 in the chart:
Export: HS 8: Medicaments of Recombinant Human Insulin, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Recombinant Human Insulin, in Measured Doses or in Retail Packings data was reported at 43.966 RMB mn in Mar 2025. This records a decrease from the previous number of 56.247 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Recombinant Human Insulin, in Measured Doses or in Retail Packings data is updated monthly, averaging 21.203 RMB mn from Jan 2015 (Median) to Mar 2025, with 121 observations. The data reached an all-time high of 135.525 RMB mn in Nov 2023 and a record low of 0.004 RMB mn in Dec 2015. CN: Export: HS 8: Medicaments of Recombinant Human Insulin, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 29.850 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Medicaments of Recombinant Human Insulin, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings
CN: Export: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data was reported at 71.826 RMB mn in Mar 2025. This records an increase from the previous number of 20.363 RMB mn for Feb 2025. CN: Export: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data is updated monthly, averaging 103.291 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 315.599 RMB mn in Mar 2022 and a record low of 4.486 RMB mn in Jan 2017. CN: Export: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 45.372 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Export: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings from Jan 2015 to Dec 2024 in the chart:
Export: HS 8: Opacifying Preparations for X-Ray Examinations; Diagnostic Reagents
CN: Export: HS 8: Opacifying Preparations for X-Ray Examinations; Diagnostic Reagents data was reported at 267.511 RMB mn in Mar 2025. This records an increase from the previous number of 213.859 RMB mn for Feb 2025. CN: Export: HS 8: Opacifying Preparations for X-Ray Examinations; Diagnostic Reagents data is updated monthly, averaging 317.132 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 637.719 RMB mn in May 2019 and a record low of 53.572 RMB mn in Apr 2022. CN: Export: HS 8: Opacifying Preparations for X-Ray Examinations; Diagnostic Reagents data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 264.675 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Opacifying Preparations for X-Ray Examinations; Diagnostic Reagents from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Other Medicaments Containing Penicillins or Their Derivatives, in Measured Doses or in Retail Packings
CN: Export: HS 8: Other Medicaments Containing Penicillins or Their Derivatives, in Measured Doses or in Retail Packings data was reported at 84.058 RMB mn in Mar 2025. This records an increase from the previous number of 77.601 RMB mn for Feb 2025. CN: Export: HS 8: Other Medicaments Containing Penicillins or Their Derivatives, in Measured Doses or in Retail Packings data is updated monthly, averaging 45.851 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 118.842 RMB mn in May 2024 and a record low of 8.116 RMB mn in Mar 2015. CN: Export: HS 8: Other Medicaments Containing Penicillins or Their Derivatives, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 104.824 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Other Medicaments Containing Penicillins or Their Derivatives, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings
CN: Export: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data was reported at 132.682 RMB mn in Mar 2025. This records an increase from the previous number of 102.950 RMB mn for Feb 2025. CN: Export: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 103.848 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 349.717 RMB mn in Mar 2022 and a record low of 48.009 RMB mn in Feb 2020. CN: Export: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 123.225 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Substances of Human or Animal Origin, for Therapeutic Uses, nes
CN: Export: HS 8: Substances of Human or Animal Origin, for Therapeutic Uses, nes data was reported at 109.676 RMB mn in Mar 2025. This records an increase from the previous number of 88.549 RMB mn for Feb 2025. CN: Export: HS 8: Substances of Human or Animal Origin, for Therapeutic Uses, nes data is updated monthly, averaging 106.190 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 214.498 RMB mn in Jun 2015 and a record low of 61.349 RMB mn in Oct 2018. CN: Export: HS 8: Substances of Human or Animal Origin, for Therapeutic Uses, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 109.186 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Export: HS 8: Substances of Human or Animal Origin, for Therapeutic Uses, nes from Jan 2015 to Nov 2024 in the chart:
Export: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings
CN: Export: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data was reported at 13.506 RMB mn in Mar 2025. This records an increase from the previous number of 1.684 RMB mn for Feb 2025. CN: Export: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 3.765 RMB mn from Feb 2017 (Median) to Mar 2025, with 96 observations. The data reached an all-time high of 25.046 RMB mn in Nov 2024 and a record low of 0.001 RMB mn in Apr 2017. CN: Export: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 25.046 Nov 2024 | monthly | Feb 2017 - Nov 2024 |
View China's Export: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings from Feb 2017 to Nov 2024 in the chart:
Export: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes
CN: Export: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data was reported at 174.410 RMB mn in Mar 2025. This records an increase from the previous number of 158.775 RMB mn for Feb 2025. CN: Export: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data is updated monthly, averaging 122.415 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 359.599 RMB mn in Mar 2022 and a record low of 55.391 RMB mn in Feb 2020. CN: Export: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 199.061 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Export: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes from Jan 2015 to Dec 2024 in the chart:
Export: HS 8: Waste Pharmaceuticals
CN: Export: HS 8: Waste Pharmaceuticals data was reported at 0.001 RMB mn in Mar 2025. This records an increase from the previous number of 0.000 RMB mn for Feb 2025. CN: Export: HS 8: Waste Pharmaceuticals data is updated monthly, averaging 0.016 RMB mn from Jan 2016 (Median) to Mar 2025, with 37 observations. The data reached an all-time high of 0.795 RMB mn in Sep 2018 and a record low of 0.000 RMB mn in Oct 2023. CN: Export: HS 8: Waste Pharmaceuticals data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.003 Nov 2024 | monthly | Jan 2016 - Nov 2024 |
View China's Export: HS 8: Waste Pharmaceuticals from Jan 2016 to Nov 2024 in the chart:
Import: HS 8: Absorbent Cotton, Bandage, Gauzes for Retail Sale
CN: Import: HS 8: Absorbent Cotton, Bandage, Gauzes for Retail Sale data was reported at 3.698 RMB mn in Mar 2025. This records an increase from the previous number of 2.831 RMB mn for Feb 2025. CN: Import: HS 8: Absorbent Cotton, Bandage, Gauzes for Retail Sale data is updated monthly, averaging 5.012 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 16.241 RMB mn in Feb 2018 and a record low of 1.907 RMB mn in Jan 2022. CN: Import: HS 8: Absorbent Cotton, Bandage, Gauzes for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2.566 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Absorbent Cotton, Bandage, Gauzes for Retail Sale from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Antisera and Other Blood Fraction
CN: Import: HS 8: Antisera and Other Blood Fraction data was reported at 1,922.548 RMB mn in Mar 2025. This records an increase from the previous number of 1,577.923 RMB mn for Feb 2025. CN: Import: HS 8: Antisera and Other Blood Fraction data is updated monthly, averaging 1,206.142 RMB mn from Jan 2017 (Median) to Mar 2025, with 99 observations. The data reached an all-time high of 1,922.548 RMB mn in Mar 2025 and a record low of 404.130 RMB mn in Feb 2018. CN: Import: HS 8: Antisera and Other Blood Fraction data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 1,846.493 Dec 2024 | monthly | Jan 2017 - Dec 2024 |
View China's Import: HS 8: Antisera and Other Blood Fraction from Jan 2017 to Dec 2024 in the chart:
Import: HS 8: Antisera, Other Blood Fractions and Immunological Products
CN: Import: HS 8: Antisera, Other Blood Fractions and Immunological Products data was reported at 3,431.715 RMB mn in Dec 2016. This records a decrease from the previous number of 3,554.878 RMB mn for Nov 2016. CN: Import: HS 8: Antisera, Other Blood Fractions and Immunological Products data is updated monthly, averaging 2,560.648 RMB mn from Jan 2015 (Median) to Dec 2016, with 24 observations. The data reached an all-time high of 3,833.714 RMB mn in Dec 2015 and a record low of 932.233 RMB mn in Feb 2016. CN: Import: HS 8: Antisera, Other Blood Fractions and Immunological Products data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 3,431.715 Dec 2016 | monthly | Jan 2015 - Dec 2016 |
View China's Import: HS 8: Antisera, Other Blood Fractions and Immunological Products from Jan 2015 to Dec 2016 in the chart:
Import: HS 8: Appliances Identifiable for Ostomy Use
CN: Import: HS 8: Appliances Identifiable for Ostomy Use data was reported at 44.504 RMB mn in Mar 2025. This records a decrease from the previous number of 58.367 RMB mn for Feb 2025. CN: Import: HS 8: Appliances Identifiable for Ostomy Use data is updated monthly, averaging 28.981 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 76.149 RMB mn in Apr 2021 and a record low of 3.163 RMB mn in Feb 2015. CN: Import: HS 8: Appliances Identifiable for Ostomy Use data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 36.101 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Appliances Identifiable for Ostomy Use from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Blood-Grouping Reagents
CN: Import: HS 8: Blood-Grouping Reagents data was reported at 35.148 RMB mn in Dec 2021. This records a decrease from the previous number of 40.423 RMB mn for Nov 2021. CN: Import: HS 8: Blood-Grouping Reagents data is updated monthly, averaging 28.471 RMB mn from Jan 2015 (Median) to Dec 2021, with 84 observations. The data reached an all-time high of 52.082 RMB mn in Aug 2020 and a record low of 5.818 RMB mn in Feb 2016. CN: Import: HS 8: Blood-Grouping Reagents data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 35.148 Dec 2021 | monthly | Jan 2015 - Dec 2021 |
View China's Import: HS 8: Blood-Grouping Reagents from Jan 2015 to Dec 2021 in the chart:
Import: HS 8: Contraceptive Preparations Based on Hormones
CN: Import: HS 8: Contraceptive Preparations Based on Hormones data was reported at 146.068 RMB mn in Mar 2025. This records an increase from the previous number of 106.270 RMB mn for Jan 2025. CN: Import: HS 8: Contraceptive Preparations Based on Hormones data is updated monthly, averaging 67.307 RMB mn from Jan 2015 (Median) to Mar 2025, with 121 observations. The data reached an all-time high of 329.890 RMB mn in Sep 2023 and a record low of 0.002 RMB mn in Oct 2015. CN: Import: HS 8: Contraceptive Preparations Based on Hormones data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 73.135 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Contraceptive Preparations Based on Hormones from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Essential Balm, in Measured Doses or in Retail Packings
CN: Import: HS 8: Essential Balm, in Measured Doses or in Retail Packings data was reported at 10.853 RMB mn in Mar 2025. This records an increase from the previous number of 0.299 RMB mn for Feb 2025. CN: Import: HS 8: Essential Balm, in Measured Doses or in Retail Packings data is updated monthly, averaging 9.229 RMB mn from Jun 2015 (Median) to Mar 2025, with 81 observations. The data reached an all-time high of 66.981 RMB mn in Oct 2021 and a record low of 0.001 RMB mn in Jan 2019. CN: Import: HS 8: Essential Balm, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 9.985 Nov 2024 | monthly | Jun 2015 - Nov 2024 |
View China's Import: HS 8: Essential Balm, in Measured Doses or in Retail Packings from Jun 2015 to Nov 2024 in the chart:
Import: HS 8: First-Aid Boxes and Kits
CN: Import: HS 8: First-Aid Boxes and Kits data was reported at 1.694 RMB mn in Mar 2025. This records an increase from the previous number of 0.781 RMB mn for Feb 2025. CN: Import: HS 8: First-Aid Boxes and Kits data is updated monthly, averaging 3.035 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 6.536 RMB mn in Nov 2018 and a record low of 0.781 RMB mn in Feb 2025. CN: Import: HS 8: First-Aid Boxes and Kits data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.976 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: First-Aid Boxes and Kits from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Gel Preparations Designed to Be Used in Human or Veterinary Medicine
CN: Import: HS 8: Gel Preparations Designed to Be Used in Human or Veterinary Medicine data was reported at 8.326 RMB mn in Mar 2025. This records an increase from the previous number of 7.635 RMB mn for Feb 2025. CN: Import: HS 8: Gel Preparations Designed to Be Used in Human or Veterinary Medicine data is updated monthly, averaging 10.610 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 33.283 RMB mn in Nov 2018 and a record low of 1.895 RMB mn in Jan 2022. CN: Import: HS 8: Gel Preparations Designed to Be Used in Human or Veterinary Medicine data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 10.192 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Gel Preparations Designed to Be Used in Human or Veterinary Medicine from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Heparin and Its Salts
CN: Import: HS 8: Heparin and Its Salts data was reported at 46.861 RMB mn in Mar 2025. This records an increase from the previous number of 18.535 RMB mn for Feb 2025. CN: Import: HS 8: Heparin and Its Salts data is updated monthly, averaging 25.821 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 233.532 RMB mn in Dec 2022 and a record low of 0.004 RMB mn in Jun 2015. CN: Import: HS 8: Heparin and Its Salts data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 8.501 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Heparin and Its Salts from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Immunological Products, in Measured Doses or in Retail Packings
CN: Import: HS 8: Immunological Products, in Measured Doses or in Retail Packings data was reported at 7,113.927 RMB mn in Mar 2025. This records an increase from the previous number of 6,090.134 RMB mn for Feb 2025. CN: Import: HS 8: Immunological Products, in Measured Doses or in Retail Packings data is updated monthly, averaging 3,927.707 RMB mn from Jan 2017 (Median) to Mar 2025, with 99 observations. The data reached an all-time high of 8,181.321 RMB mn in Mar 2021 and a record low of 945.924 RMB mn in Feb 2017. CN: Import: HS 8: Immunological Products, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 4,499.859 Nov 2024 | monthly | Jan 2017 - Nov 2024 |
View China's Import: HS 8: Immunological Products, in Measured Doses or in Retail Packings from Jan 2017 to Nov 2024 in the chart:
Import: HS 8: Materials for Surgical Sutures; Laminaria; Absorbable Haemostatics
CN: Import: HS 8: Materials for Surgical Sutures; Laminaria; Absorbable Haemostatics data was reported at 140.395 RMB mn in Mar 2025. This records an increase from the previous number of 125.907 RMB mn for Feb 2025. CN: Import: HS 8: Materials for Surgical Sutures; Laminaria; Absorbable Haemostatics data is updated monthly, averaging 125.514 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 204.772 RMB mn in Mar 2021 and a record low of 62.107 RMB mn in Dec 2022. CN: Import: HS 8: Materials for Surgical Sutures; Laminaria; Absorbable Haemostatics data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 144.421 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Import: HS 8: Materials for Surgical Sutures; Laminaria; Absorbable Haemostatics from Jan 2015 to Dec 2024 in the chart:
Import: HS 8: Medicaments Containing Streptomycins or Their Derivatives, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments Containing Streptomycins or Their Derivatives, in Measured Doses or in Retail Packings data was reported at 0.013 RMB mn in Mar 2025. This records a decrease from the previous number of 0.287 RMB mn for Jan 2025. CN: Import: HS 8: Medicaments Containing Streptomycins or Their Derivatives, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.100 RMB mn from Jan 2015 (Median) to Mar 2025, with 100 observations. The data reached an all-time high of 21.309 RMB mn in Sep 2015 and a record low of 0.000 RMB mn in Jun 2018. CN: Import: HS 8: Medicaments Containing Streptomycins or Their Derivatives, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.013 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments Containing Streptomycins or Their Derivatives, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes
CN: Import: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data was reported at 8.925 RMB mn in Dec 2016. This records an increase from the previous number of 6.724 RMB mn for Nov 2016. CN: Import: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data is updated monthly, averaging 6.724 RMB mn from Jan 2015 (Median) to Dec 2016, with 19 observations. The data reached an all-time high of 17.213 RMB mn in Sep 2015 and a record low of 0.072 RMB mn in Apr 2016. CN: Import: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 8.925 Dec 2016 | monthly | Jan 2015 - Dec 2016 |
View China's Import: HS 8: Medicaments of Alkaloids or Their Derivatives, Not for Retail Sale, nes from Jan 2015 to Dec 2016 in the chart:
Import: HS 8: Medicaments of Amoxycillin, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Amoxycillin, Neither in Measured Doses Nor in Retail Packings data was reported at 0.032 RMB mn in Feb 2025. This records an increase from the previous number of 0.003 RMB mn for Nov 2024. CN: Import: HS 8: Medicaments of Amoxycillin, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 2.501 RMB mn from Feb 2015 (Median) to Feb 2025, with 46 observations. The data reached an all-time high of 14.679 RMB mn in Nov 2023 and a record low of 0.003 RMB mn in Nov 2024. CN: Import: HS 8: Medicaments of Amoxycillin, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.003 Nov 2024 | monthly | Feb 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Amoxycillin, Neither in Measured Doses Nor in Retail Packings from Feb 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data was reported at 3.244 RMB mn in Feb 2025. This records an increase from the previous number of 0.008 RMB mn for Jan 2025. CN: Import: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 3.256 RMB mn from Jan 2015 (Median) to Feb 2025, with 104 observations. The data reached an all-time high of 91.007 RMB mn in Jul 2017 and a record low of 0.001 RMB mn in Jul 2021. CN: Import: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.936 Sep 2024 | monthly | Jan 2015 - Sep 2024 |
View China's Import: HS 8: Medicaments of Antibiotics, nes, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Sep 2024 in the chart:
Import: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data was reported at 821.506 RMB mn in Mar 2025. This records an increase from the previous number of 668.287 RMB mn for Feb 2025. CN: Import: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 672.200 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 1,251.304 RMB mn in Mar 2020 and a record low of 289.453 RMB mn in Feb 2016. CN: Import: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 995.087 Dec 2024 | monthly | Jan 2015 - Dec 2024 |
View China's Import: HS 8: Medicaments of Antibiotics, nes, in Measured Doses or in Retail Packings from Jan 2015 to Dec 2024 in the chart:
Import: HS 8: Medicaments of Artemisinins and Their Derivatives, Not for Retail Sale
CN: Import: HS 8: Medicaments of Artemisinins and Their Derivatives, Not for Retail Sale data was reported at 0.701 RMB mn in Oct 2016. This records an increase from the previous number of 0.025 RMB mn for Aug 2016. CN: Import: HS 8: Medicaments of Artemisinins and Their Derivatives, Not for Retail Sale data is updated monthly, averaging 0.909 RMB mn from Jul 2015 (Median) to Oct 2016, with 6 observations. The data reached an all-time high of 1.601 RMB mn in Jul 2015 and a record low of 0.025 RMB mn in Aug 2016. CN: Import: HS 8: Medicaments of Artemisinins and Their Derivatives, Not for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.701 Oct 2016 | monthly | Jul 2015 - Oct 2016 |
View China's Import: HS 8: Medicaments of Artemisinins and Their Derivatives, Not for Retail Sale from Jul 2015 to Oct 2016 in the chart:
Import: HS 8: Medicaments of Artemisinins or Their Derivatives, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Artemisinins or Their Derivatives, in Measured Doses or in Retail Packings data was reported at 0.009 RMB mn in Feb 2025. This records an increase from the previous number of 0.004 RMB mn for Dec 2024. CN: Import: HS 8: Medicaments of Artemisinins or Their Derivatives, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.023 RMB mn from Feb 2017 (Median) to Feb 2025, with 24 observations. The data reached an all-time high of 0.592 RMB mn in Mar 2017 and a record low of 0.001 RMB mn in Mar 2024. CN: Import: HS 8: Medicaments of Artemisinins or Their Derivatives, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.043 Nov 2024 | monthly | Feb 2017 - Nov 2024 |
View China's Import: HS 8: Medicaments of Artemisinins or Their Derivatives, in Measured Doses or in Retail Packings from Feb 2017 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Cefaclor, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Cefaclor, Neither in Measured Doses Nor in Retail Packings data was reported at 0.004 RMB mn in Jun 2019. CN: Import: HS 8: Medicaments of Cefaclor, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.004 RMB mn from Jun 2019 (Median) to Jun 2019, with 1 observations. The data reached an all-time high of 0.004 RMB mn in Jun 2019 and a record low of 0.004 RMB mn in Jun 2019. CN: Import: HS 8: Medicaments of Cefaclor, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.004 Jun 2019 | monthly | Jun 2019 - Jun 2019 |
View China's Import: HS 8: Medicaments of Cefaclor, Neither in Measured Doses Nor in Retail Packings from Jun 2019 to Jun 2019 in the chart:
Import: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data was reported at 2.701 RMB mn in Oct 2024. This records an increase from the previous number of 0.768 RMB mn for Sep 2024. CN: Import: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.640 RMB mn from Mar 2015 (Median) to Oct 2024, with 38 observations. The data reached an all-time high of 7.084 RMB mn in Feb 2017 and a record low of 0.005 RMB mn in Sep 2023. CN: Import: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2.701 Oct 2024 | monthly | Mar 2015 - Oct 2024 |
View China's Import: HS 8: Medicaments of Cefaclor, in Measured Doses or in Retail Packings from Mar 2015 to Oct 2024 in the chart:
Import: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data was reported at 0.057 RMB mn in Sep 2019. CN: Import: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.057 RMB mn from Sep 2019 (Median) to Sep 2019, with 1 observations. The data reached an all-time high of 0.057 RMB mn in Sep 2019 and a record low of 0.057 RMB mn in Sep 2019. CN: Import: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.057 Sep 2019 | monthly | Sep 2019 - Sep 2019 |
View China's Import: HS 8: Medicaments of Cefoperazone, Neither in Measured Doses Nor in Retail Packings from Sep 2019 to Sep 2019 in the chart:
Import: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data was reported at 0.912 RMB mn in Dec 2022. This records a decrease from the previous number of 0.974 RMB mn for Oct 2022. CN: Import: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.912 RMB mn from Jan 2015 (Median) to Dec 2022, with 53 observations. The data reached an all-time high of 14.192 RMB mn in Jun 2015 and a record low of 0.002 RMB mn in Nov 2019. CN: Import: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.912 Dec 2022 | monthly | Jan 2015 - Dec 2022 |
View China's Import: HS 8: Medicaments of Cefoperazone, in Measured Doses or in Retail Packings from Jan 2015 to Dec 2022 in the chart:
Import: HS 8: Medicaments of Cefotaxime, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Cefotaxime, Neither in Measured Doses Nor in Retail Packings data was reported at 0.006 RMB mn in Apr 2021. CN: Import: HS 8: Medicaments of Cefotaxime, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.006 RMB mn from Apr 2021 (Median) to Apr 2021, with 1 observations. The data reached an all-time high of 0.006 RMB mn in Apr 2021 and a record low of 0.006 RMB mn in Apr 2021. CN: Import: HS 8: Medicaments of Cefotaxime, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.006 Apr 2021 | monthly | Apr 2021 - Apr 2021 |
View China's Import: HS 8: Medicaments of Cefotaxime, Neither in Measured Doses Nor in Retail Packings from Apr 2021 to Apr 2021 in the chart:
Import: HS 8: Medicaments of Cefoxitin, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Cefoxitin, Neither in Measured Doses Nor in Retail Packings data was reported at 0.032 RMB mn in Dec 2018. This records a decrease from the previous number of 0.105 RMB mn for Jul 2018. CN: Import: HS 8: Medicaments of Cefoxitin, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.068 RMB mn from Jul 2018 (Median) to Dec 2018, with 2 observations. The data reached an all-time high of 0.105 RMB mn in Jul 2018 and a record low of 0.032 RMB mn in Dec 2018. CN: Import: HS 8: Medicaments of Cefoxitin, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.032 Dec 2018 | monthly | Jul 2018 - Dec 2018 |
View China's Import: HS 8: Medicaments of Cefoxitin, Neither in Measured Doses Nor in Retail Packings from Jul 2018 to Dec 2018 in the chart:
Import: HS 8: Medicaments of Cefoxitin, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Cefoxitin, in Measured Doses or in Retail Packings data was reported at 0.171 RMB mn in Jan 2024. This records an increase from the previous number of 0.009 RMB mn for Aug 2023. CN: Import: HS 8: Medicaments of Cefoxitin, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.027 RMB mn from Mar 2017 (Median) to Jan 2024, with 38 observations. The data reached an all-time high of 0.473 RMB mn in Feb 2023 and a record low of 0.003 RMB mn in Apr 2020. CN: Import: HS 8: Medicaments of Cefoxitin, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.171 Jan 2024 | monthly | Mar 2017 - Jan 2024 |
View China's Import: HS 8: Medicaments of Cefoxitin, in Measured Doses or in Retail Packings from Mar 2017 to Jan 2024 in the chart:
Import: HS 8: Medicaments of Ceftazidime, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Ceftazidime, Neither in Measured Doses Nor in Retail Packings data was reported at 0.986 RMB mn in Aug 2022. This records an increase from the previous number of 0.034 RMB mn for Jul 2022. CN: Import: HS 8: Medicaments of Ceftazidime, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.556 RMB mn from Sep 2019 (Median) to Aug 2022, with 4 observations. The data reached an all-time high of 0.986 RMB mn in Aug 2022 and a record low of 0.034 RMB mn in Jul 2022. CN: Import: HS 8: Medicaments of Ceftazidime, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.986 Aug 2022 | monthly | Sep 2019 - Aug 2022 |
View China's Import: HS 8: Medicaments of Ceftazidime, Neither in Measured Doses Nor in Retail Packings from Sep 2019 to Aug 2022 in the chart:
Import: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data was reported at 121.881 RMB mn in Mar 2025. This records an increase from the previous number of 5.491 RMB mn for Jan 2025. CN: Import: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data is updated monthly, averaging 22.479 RMB mn from Jan 2015 (Median) to Mar 2025, with 112 observations. The data reached an all-time high of 340.154 RMB mn in Dec 2024 and a record low of 0.002 RMB mn in Jan 2015. CN: Import: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.043 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Ceftazidime, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data was reported at 2.401 RMB mn in Jan 2022. This records a decrease from the previous number of 3.646 RMB mn for Oct 2021. CN: Import: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data is updated monthly, averaging 3.034 RMB mn from Jan 2015 (Median) to Jan 2022, with 62 observations. The data reached an all-time high of 12.149 RMB mn in Jul 2015 and a record low of 0.006 RMB mn in Dec 2020. CN: Import: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 2.401 Jan 2022 | monthly | Jan 2015 - Jan 2022 |
View China's Import: HS 8: Medicaments of Ceftezole, in Measured Doses or in Retail Packings from Jan 2015 to Jan 2022 in the chart:
Import: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data was reported at 11.090 RMB mn in Jan 2025. This records an increase from the previous number of 4.624 RMB mn for Dec 2024. CN: Import: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data is updated monthly, averaging 5.702 RMB mn from Apr 2015 (Median) to Jan 2025, with 112 observations. The data reached an all-time high of 41.403 RMB mn in Dec 2019 and a record low of 0.003 RMB mn in Jul 2020. CN: Import: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 5.412 Nov 2024 | monthly | Apr 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Ceftriaxone, in Measured Doses or in Retail Packings from Apr 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data was reported at 0.007 RMB mn in Aug 2021. This records a decrease from the previous number of 0.124 RMB mn for Aug 2019. CN: Import: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.031 RMB mn from May 2015 (Median) to Aug 2021, with 5 observations. The data reached an all-time high of 0.124 RMB mn in Aug 2019 and a record low of 0.007 RMB mn in Aug 2021. CN: Import: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.007 Aug 2021 | monthly | May 2015 - Aug 2021 |
View China's Import: HS 8: Medicaments of Cefuroxime, Neither in Measured Doses Nor in Retail Packings from May 2015 to Aug 2021 in the chart:
Import: HS 8: Medicaments of Cefuroxime, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Cefuroxime, in Measured Doses or in Retail Packings data was reported at 0.027 RMB mn in Mar 2025. This records an increase from the previous number of 0.009 RMB mn for Feb 2025. CN: Import: HS 8: Medicaments of Cefuroxime, in Measured Doses or in Retail Packings data is updated monthly, averaging 40.216 RMB mn from Jan 2015 (Median) to Mar 2025, with 119 observations. The data reached an all-time high of 112.464 RMB mn in Nov 2021 and a record low of 0.004 RMB mn in Jun 2023. CN: Import: HS 8: Medicaments of Cefuroxime, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 6.395 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Cefuroxime, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Ephedrine or Its Salts, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Ephedrine or Its Salts, in Measured Doses or in Retail Packings data was reported at 0.031 RMB mn in Jul 2023. This records an increase from the previous number of 0.011 RMB mn for Jan 2023. CN: Import: HS 8: Medicaments of Ephedrine or Its Salts, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.025 RMB mn from Aug 2021 (Median) to Jul 2023, with 4 observations. The data reached an all-time high of 0.041 RMB mn in Jun 2022 and a record low of 0.011 RMB mn in Jan 2023. CN: Import: HS 8: Medicaments of Ephedrine or Its Salts, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.031 Jul 2023 | monthly | Aug 2021 - Jul 2023 |
View China's Import: HS 8: Medicaments of Ephedrine or Its Salts, in Measured Doses or in Retail Packings from Aug 2021 to Jul 2023 in the chart:
Import: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data was reported at 0.310 RMB mn in Apr 2024. This records a decrease from the previous number of 7.393 RMB mn for Jul 2022. CN: Import: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.399 RMB mn from Jan 2015 (Median) to Apr 2024, with 36 observations. The data reached an all-time high of 13.351 RMB mn in Nov 2017 and a record low of 0.002 RMB mn in Jun 2019. CN: Import: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.310 Apr 2024 | monthly | Jan 2015 - Apr 2024 |
View China's Import: HS 8: Medicaments of Hormones or Other Products of Heading 29.37, nes, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Apr 2024 in the chart:
Import: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data was reported at 0.007 RMB mn in Jan 2015. CN: Import: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.007 RMB mn from Jan 2015 (Median) to Jan 2015, with 1 observations. The data reached an all-time high of 0.007 RMB mn in Jan 2015 and a record low of 0.007 RMB mn in Jan 2015. CN: Import: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.007 Jan 2015 | monthly | Jan 2015 - Jan 2015 |
View China's Import: HS 8: Medicaments of Insulin, Neither in Measured Doses Nor in Retail Packings from Jan 2015 to Jan 2015 in the chart:
Import: HS 8: Medicaments of Norephedrine or Its Salts, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Norephedrine or Its Salts, in Measured Doses or in Retail Packings data was reported at 0.002 RMB mn in Nov 2024. This records a decrease from the previous number of 0.004 RMB mn for Jan 2023. CN: Import: HS 8: Medicaments of Norephedrine or Its Salts, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.003 RMB mn from Jan 2023 (Median) to Nov 2024, with 2 observations. The data reached an all-time high of 0.004 RMB mn in Jan 2023 and a record low of 0.002 RMB mn in Nov 2024. CN: Import: HS 8: Medicaments of Norephedrine or Its Salts, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.002 Nov 2024 | monthly | Jan 2023 - Nov 2024 |
View China's Import: HS 8: Medicaments of Norephedrine or Its Salts, in Measured Doses or in Retail Packings from Jan 2023 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Other Alkaloids or Their Derivatives, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Other Alkaloids or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data was reported at 17.279 RMB mn in May 2023. This records an increase from the previous number of 12.687 RMB mn for Apr 2023. CN: Import: HS 8: Medicaments of Other Alkaloids or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 9.249 RMB mn from Jan 2017 (Median) to May 2023, with 70 observations. The data reached an all-time high of 27.443 RMB mn in Mar 2023 and a record low of 0.047 RMB mn in Jan 2018. CN: Import: HS 8: Medicaments of Other Alkaloids or Their Derivatives, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 21.997 Nov 2024 | monthly | Jan 2017 - Nov 2024 |
View China's Import: HS 8: Medicaments of Other Alkaloids or Their Derivatives, Neither in Measured Doses Nor in Retail Packings from Jan 2017 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Other Antimalarial Active Principles, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Other Antimalarial Active Principles, Neither in Measured Doses Nor in Retail Packings data was reported at 1.209 RMB mn in Jun 2023. This records an increase from the previous number of 0.264 RMB mn for May 2023. CN: Import: HS 8: Medicaments of Other Antimalarial Active Principles, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 1.256 RMB mn from Sep 2020 (Median) to Jun 2023, with 4 observations. The data reached an all-time high of 1.819 RMB mn in May 2021 and a record low of 0.264 RMB mn in May 2023. CN: Import: HS 8: Medicaments of Other Antimalarial Active Principles, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 1.209 Jun 2023 | monthly | Sep 2020 - Jun 2023 |
View China's Import: HS 8: Medicaments of Other Antimalarial Active Principles, Neither in Measured Doses Nor in Retail Packings from Sep 2020 to Jun 2023 in the chart:
Import: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data was reported at 0.013 RMB mn in Jan 2025. This records a decrease from the previous number of 0.015 RMB mn for Nov 2024. CN: Import: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data is updated monthly, averaging 210.287 RMB mn from Jan 2015 (Median) to Jan 2025, with 107 observations. The data reached an all-time high of 559.155 RMB mn in Jan 2021 and a record low of 0.002 RMB mn in Apr 2024. CN: Import: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.015 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Other Insulin, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data was reported at 0.037 RMB mn in Oct 2021. This records an increase from the previous number of 0.007 RMB mn for Mar 2019. CN: Import: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 0.022 RMB mn from May 2017 (Median) to Oct 2021, with 4 observations. The data reached an all-time high of 0.037 RMB mn in May 2017 and a record low of 0.004 RMB mn in Feb 2018. CN: Import: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.037 Oct 2021 | monthly | May 2017 - Oct 2021 |
View China's Import: HS 8: Medicaments of Other Penicillins or Derivatives, Neither in Measured Doses Nor in Retail Packings from May 2017 to Oct 2021 in the chart:
Import: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data was reported at 0.001 RMB mn in Dec 2024. This records a decrease from the previous number of 0.003 RMB mn for Aug 2024. CN: Import: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data is updated monthly, averaging 0.000 RMB mn from Feb 2017 (Median) to Dec 2024, with 11 observations. The data reached an all-time high of 0.003 RMB mn in Aug 2024 and a record low of 0.000 RMB mn in Jun 2017. CN: Import: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.002 May 2024 | monthly | Feb 2017 - May 2024 |
View China's Import: HS 8: Medicaments of Pseudoephedrine (INN) or Its Salts, in Measured Doses or in Retail Packings from Feb 2017 to May 2024 in the chart:
Import: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale
CN: Import: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data was reported at 0.135 RMB mn in Nov 2016. This records a decrease from the previous number of 0.756 RMB mn for Oct 2016. CN: Import: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data is updated monthly, averaging 0.264 RMB mn from May 2015 (Median) to Nov 2016, with 7 observations. The data reached an all-time high of 0.991 RMB mn in Aug 2015 and a record low of 0.108 RMB mn in May 2015. CN: Import: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.135 Nov 2016 | monthly | May 2015 - Nov 2016 |
View China's Import: HS 8: Medicaments of Quinine or Its Salts, Not for Retail Sale from May 2015 to Nov 2016 in the chart:
Import: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale
CN: Import: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data was reported at 0.001 RMB mn in Feb 2016. CN: Import: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data is updated monthly, averaging 0.001 RMB mn from Feb 2016 (Median) to Feb 2016, with 1 observations. The data reached an all-time high of 0.001 RMB mn in Feb 2016 and a record low of 0.001 RMB mn in Feb 2016. CN: Import: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.001 Feb 2016 | monthly | Feb 2016 - Feb 2016 |
View China's Import: HS 8: Medicaments of Quinine or Its Salts, for Retail Sale from Feb 2016 to Feb 2016 in the chart:
Import: HS 8: Medicaments of Sulfa Drugs, Not for Retail Sale
CN: Import: HS 8: Medicaments of Sulfa Drugs, Not for Retail Sale data was reported at 0.002 RMB mn in Sep 2015. This records an increase from the previous number of 0.002 RMB mn for Aug 2015. CN: Import: HS 8: Medicaments of Sulfa Drugs, Not for Retail Sale data is updated monthly, averaging 0.002 RMB mn from Aug 2015 (Median) to Sep 2015, with 2 observations. The data reached an all-time high of 0.002 RMB mn in Sep 2015 and a record low of 0.002 RMB mn in Aug 2015. CN: Import: HS 8: Medicaments of Sulfa Drugs, Not for Retail Sale data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.002 Sep 2015 | monthly | Aug 2015 - Sep 2015 |
View China's Import: HS 8: Medicaments of Sulfa Drugs, Not for Retail Sale from Aug 2015 to Sep 2015 in the chart:
Import: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings
CN: Import: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data was reported at 422.799 RMB mn in Mar 2025. This records an increase from the previous number of 381.055 RMB mn for Feb 2025. CN: Import: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data is updated monthly, averaging 267.192 RMB mn from Jan 2015 (Median) to Mar 2025, with 121 observations. The data reached an all-time high of 810.900 RMB mn in Dec 2023 and a record low of 0.334 RMB mn in Aug 2015. CN: Import: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 615.274 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Medicaments of Sulfa Drugs, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Other Blood Fractions or Immunological Products
CN: Import: HS 8: Other Blood Fractions or Immunological Products data was reported at 30.016 RMB mn in Dec 2021. This records a decrease from the previous number of 35.026 RMB mn for Nov 2021. CN: Import: HS 8: Other Blood Fractions or Immunological Products data is updated monthly, averaging 156.627 RMB mn from Jan 2017 (Median) to Dec 2021, with 60 observations. The data reached an all-time high of 618.427 RMB mn in Jan 2017 and a record low of 7.190 RMB mn in Feb 2021. CN: Import: HS 8: Other Blood Fractions or Immunological Products data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 30.016 Dec 2021 | monthly | Jan 2017 - Dec 2021 |
View China's Import: HS 8: Other Blood Fractions or Immunological Products from Jan 2017 to Dec 2021 in the chart:
Import: HS 8: Other Chemical Contraceptive Preparations Based on Hormones or Spermicides
CN: Import: HS 8: Other Chemical Contraceptive Preparations Based on Hormones or Spermicides data was reported at 0.023 RMB mn in Jan 2020. This records an increase from the previous number of 0.002 RMB mn for Nov 2019. CN: Import: HS 8: Other Chemical Contraceptive Preparations Based on Hormones or Spermicides data is updated monthly, averaging 0.024 RMB mn from Feb 2018 (Median) to Jan 2020, with 12 observations. The data reached an all-time high of 0.065 RMB mn in Jul 2019 and a record low of 0.002 RMB mn in Nov 2019. CN: Import: HS 8: Other Chemical Contraceptive Preparations Based on Hormones or Spermicides data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 0.023 Jan 2020 | monthly | Feb 2018 - Jan 2020 |
View China's Import: HS 8: Other Chemical Contraceptive Preparations Based on Hormones or Spermicides from Feb 2018 to Jan 2020 in the chart:
Import: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings
CN: Import: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data was reported at 168.151 RMB mn in Mar 2025. This records an increase from the previous number of 142.077 RMB mn for Feb 2025. CN: Import: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data is updated monthly, averaging 209.026 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 420.487 RMB mn in Mar 2020 and a record low of 19.632 RMB mn in May 2015. CN: Import: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 263.886 Nov 2024 | monthly | Jan 2015 - Nov 2024 |
View China's Import: HS 8: Other Medicaments of Chinese Type, nes, in Measured Doses or in Retail Packings from Jan 2015 to Nov 2024 in the chart:
Import: HS 8: Other Medicaments with≥2 Constituents, Not for Retail Sale, nes
CN: Import: HS 8: Other Medicaments with≥2 Constituents, Not for Retail Sale, nes data was reported at 72.409 RMB mn in Dec 2016. This records a decrease from the previous number of 161.808 RMB mn for Nov 2016. CN: Import: HS 8: Other Medicaments with≥2 Constituents, Not for Retail Sale, nes data is updated monthly, averaging 108.555 RMB mn from Jan 2015 (Median) to Dec 2016, with 24 observations. The data reached an all-time high of 165.763 RMB mn in Jul 2015 and a record low of 47.121 RMB mn in Jan 2016. CN: Import: HS 8: Other Medicaments with≥2 Constituents, Not for Retail Sale, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 72.409 Dec 2016 | monthly | Jan 2015 - Dec 2016 |
View China's Import: HS 8: Other Medicaments with≥2 Constituents, Not for Retail Sale, nes from Jan 2015 to Dec 2016 in the chart:
Import: HS 8: Other Toxins, Cultured Microorganisms, Similar Products
CN: Import: HS 8: Other Toxins, Cultured Microorganisms, Similar Products data was reported at 243.607 RMB mn in Mar 2025. This records a decrease from the previous number of 311.403 RMB mn for Feb 2025. CN: Import: HS 8: Other Toxins, Cultured Microorganisms, Similar Products data is updated monthly, averaging 235.086 RMB mn from Jan 2022 (Median) to Mar 2025, with 39 observations. The data reached an all-time high of 941.074 RMB mn in May 2022 and a record low of 0.321 RMB mn in Apr 2022. CN: Import: HS 8: Other Toxins, Cultured Microorganisms, Similar Products data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 51.161 Dec 2024 | monthly | Jan 2022 - Dec 2024 |
View China's Import: HS 8: Other Toxins, Cultured Microorganisms, Similar Products from Jan 2022 to Dec 2024 in the chart:
Import: HS 8: Placebos and Blinded (or Double-Blinded) Clinical Trial Kits for a Recognised Clinical Trial, Put up in Measured Doses
CN: Import: HS 8: Placebos and Blinded (or Double-Blinded) Clinical Trial Kits for a Recognised Clinical Trial, Put up in Measured Doses data was reported at 34.737 RMB mn in Mar 2025. This records a decrease from the previous number of 38.966 RMB mn for Feb 2025. CN: Import: HS 8: Placebos and Blinded (or Double-Blinded) Clinical Trial Kits for a Recognised Clinical Trial, Put up in Measured Doses data is updated monthly, averaging 40.935 RMB mn from Jan 2022 (Median) to Mar 2025, with 39 observations. The data reached an all-time high of 128.920 RMB mn in May 2022 and a record low of 2.253 RMB mn in Jan 2022. CN: Import: HS 8: Placebos and Blinded (or Double-Blinded) Clinical Trial Kits for a Recognised Clinical Trial, Put up in Measured Doses data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 67.876 Nov 2024 | monthly | Jan 2022 - Nov 2024 |
View China's Import: HS 8: Placebos and Blinded (or Double-Blinded) Clinical Trial Kits for a Recognised Clinical Trial, Put up in Measured Doses from Jan 2022 to Nov 2024 in the chart:
Import: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings
CN: Import: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data was reported at 63.788 RMB mn in Mar 2025. This records an increase from the previous number of 21.880 RMB mn for Feb 2025. CN: Import: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data is updated monthly, averaging 39.094 RMB mn from Feb 2017 (Median) to Mar 2025, with 98 observations. The data reached an all-time high of 99.657 RMB mn in Dec 2024 and a record low of 0.000 RMB mn in Feb 2017. CN: Import: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 41.949 Nov 2024 | monthly | Feb 2017 - Nov 2024 |
View China's Import: HS 8: Unmixed Immunological Products, Neither in Measured Doses Nor in Retail Packings from Feb 2017 to Nov 2024 in the chart:
Import: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes
CN: Import: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data was reported at 46.367 RMB mn in Mar 2025. This records an increase from the previous number of 32.755 RMB mn for Feb 2025. CN: Import: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data is updated monthly, averaging 32.838 RMB mn from Jan 2015 (Median) to Mar 2025, with 123 observations. The data reached an all-time high of 86.579 RMB mn in Aug 2022 and a record low of 8.462 RMB mn in Feb 2015. CN: Import: HS 8: Wadding and Simar Articles, for Medical Use, for Retail Sale, nes data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s International Trade – Table CN.JKF: RMB: HS30: Pharmaceutical Products.
| Last | Frequency | Range |
|---|---|---|
| 38.368 Nov 2024 | monthly | Jan 2015 - Nov 2024 |